Workshop on biosimilars

Date: 31/10/2013
Location: European Medicines Agency, London, UK
The workshop is intended to discuss the draft guideline on similar biological medical products, the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues, and the draft guideline on similar biological medical products containing biotechnology-derived proteins as active substance: quality issues. Registration closed.

Documents

Multimedia

How useful was this page?

Add your rating